CytomX Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. CytomX Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 90% to $101,214,000. The net income raised on -$569,000 and profit margin reached -1%. Total operating expenses were $107,698,000.
Profit Margin
| 2014 | 5.07M | -30.31M | -597.01% |
|---|---|---|---|
| 2015 | 7.71M | -35.37M | -458.69% |
| 2016 | 15.04M | -58.9M | -391.54% |
| 2017 | 71.62M | -43.09M | -60.17% |
| 2018 | 59.50M | -84.60M | -142.19% |
| 2019 | 57.48M | -102.23M | -177.84% |
| 2020 | 100.36M | -32.88M | -32.77% |
| 2021 | 69.57M | -80.64M | -115.92% |
| 2022 | 53.16M | -97.29M | -183.02% |
| 2023 | 101.21M | -569K | -0.56% |
CTMX Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 101.21M | 53.16M | 69.57M | 100.36M | 57.48M | 59.50M | 71.62M | 15.04M | 7.71M | 5.07M |
Cost of revenue | 0 | 5.85M | 5.83M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 101.21M | 47.30M | 63.73M | 100.36M | 57.48M | 59.50M | 71.62M | 15.04M | 7.71M | 5.07M |
Operating exp. | ||||||||||
Research and development | 77.68M | 111.64M | 114.19M | 112.93M | 131.61M | 103.86M | 92.27M | 54.75M | 28.35M | 28.30M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 107.69M | 154.49M | 153.35M | 148.96M | 168.38M | 137.37M | 117.88M | 74.62M | 40.91M | 34.84M |
Operating income | -6.48M | -101.33M | -83.78M | -48.60M | -110.89M | -77.87M | -46.25M | -59.58M | -33.20M | -29.76M |
Other income (expenses), net | 9.80M | 2.01M | 172K | 1.80M | 8.23M | -68K | 2.64M | -69K | -2.16M | -535K |
Income before tax | 3.32M | -99.31M | -83.60M | -46.79M | -102.66M | -70.30M | -43.61M | -58.91M | -35.36M | -30.3M |
Income tax expense | 3.89M | -2.01M | -2.96M | -13.91M | -427K | 14.30M | -513K | -19K | 10K | 10K |
Net income | -569K | -97.29M | -80.64M | -32.88M | -102.23M | -84.60M | -43.09M | -58.9M | -35.37M | -30.31M |
Earnings per share | ||||||||||
Basic EPS | -0.00 | -1.48 | -1.26 | -0.71 | -2.26 | -2.03 | -1.16 | -1.63 | -4.12 | -0.87 |
Diluted EPS | -0.00 | -1.48 | -1.26 | -0.71 | -2.26 | -2.03 | -1.16 | -1.63 | -4.12 | -0.87 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |